| 12:00 p.m. |
|
Other Tri-Institutional Events
Cell Signaling, Systems-based Pharmacology, and the Future of Precision Cancer Medicine
Michael B. Yaffe, Ph.D., director, MIT Center for Precision Cancer Medicine, David H. Koch Professor in Science, professor of biological engineering, Massachusetts Institute of Technology
|
| 1:30 p.m. |
|
Other Tri-Institutional Events
NK Cell Activation and Desensitization: Mobilizing the cGAS-STING Pathway and Cytokines for NK-Mediated Immunotherapy of Cancer
David Raulet, Ph.D., professor, Schekman Chair in Cancer Biology, director, Immunotherapeutics and Vaccine Research Initiative, professor of immunology and pathogenesis, University of California, Berkeley
|
